Home › Companies › CYTEK BIOSCIENCES INC. › 2023-2024
Compiled from SEC Form N-PX filings and CYTEK BIOSCIENCES INC.’s Form 8-K, filed 2024-06-11 (Item 5.07 on EDGAR). Page generated 04 October 2026.
Explore CYTEK BIOSCIENCES INC. in the interactive database Compare manager voting policies
These tallies are CYTEK BIOSCIENCES INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2024-06-11 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Outcome |
|---|---|---|---|---|---|---|
| Elect Director: Wenbin Jiang, Ph.D. | 64,177,338 | -- | -- | 9,915,036 | 23,010,427 | Majority: yes |
| Elect Director: Michael Holder | 70,298,785 | -- | -- | 3,793,589 | 23,010,427 | Majority: yes |
| Proposal 2: Executive Compensation. On an advisory basis, compensation paid to the Company's named executive officers for the year ended December 31, 2023 was approved based on the following results of voting: | 63,537,386 | 10,476,039 | 78,949 | -- | 23,010,427 | Passed |
| Proposal 3: Ratification of the Selection of Independent Registered Public Accounting Firm. The selection of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024 was ratified based on | 94,116,564 | 2,329,549 | 656,688 | -- | -- | Majority: yes |
Source: CYTEK BIOSCIENCES INC., Form 8-K, filed with the SEC on 2024-06-11 — read the filing on EDGAR.
Each item below shows how the 164 asset managers that disclosed a CYTEK BIOSCIENCES INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of CYTEK BIOSCIENCES INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Combines 5 wordings of this item as funds reported it.
86% Passed · of votes cast
CYTEK BIOSCIENCES INC.’s own tally for this item (“Proposal 2: Executive Compensation. On an advisory basis, compensation paid to the Company's named executive officers for the year ended December 31, 2023 was approved based on the following results of voting:”): 63,537,386 for, 10,476,039 against — passed, per its Form 8-K filed 2024-06-11 (Item 5.07). Of all 131,272,929 outstanding shares: 48.4% for, 8% against (56% of the company cast a for/against vote).
The 164 asset managers below cast 81% of the shares they voted on this item FOR (56,539,921 for, 12,949,026 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 12,024,964 | 0 | 0 | 0 | For |
| BlackRock | 10,426,910 | 0 | 0 | 0 | For |
| HHLR ADVISORS, LTD. | 6,657,030 | 0 | 0 | 0 | For |
| BROWN CAPITAL MANAGEMENT LLC | 0 | 6,372,032 | 0 | 0 | Against |
| Brown Capital Management Mutual Funds | 0 | 4,548,308 | 0 | 0 | Against |
| State Street | 4,229,130 | 40,759 | 0 | 0 | For |
| RA CAPITAL MANAGEMENT, L.P. | 3,870,043 | 0 | 0 | 0 | For |
| NEW YORK STATE COMMON RETIREMENT FUND | 2,947,986 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 2,130,438 | 0 | 0 | 0 | For |
| Fidelity | 2,044,746 | 0 | 0 | 0 | For |
| Charles Schwab | 1,746,356 | 0 | 0 | 0 | For |
| Wellington | 1,255,937 | 0 | 0 | 0 | For |
| Dimensional | 904,544 | 0 | 0 | 0 | For |
| Northern Trust | 859,574 | 81 | 0 | 0 | For |
| MELLON INVESTMENTS Corp | 647,784 | 0 | 0 | 0 | For |
| Hartford | 552,629 | 0 | 0 | 0 | For |
| Impresa Management LLC | 517,790 | 0 | 0 | 0 | For |
| PRINCIPAL GLOBAL INVESTORS | 516,466 | 0 | 0 | 0 | For |
| Invesco | 0 | 369,947 | 0 | 0 | Against |
| Northwestern Mutual | 355,511 | 0 | 0 | 0 | For |
| Nationwide | 25,462 | 300,183 | 0 | 0 | Against |
| Nuveen | 305,665 | 0 | 0 | 0 | For |
| TIAA | 302,499 | 0 | 0 | 0 | For |
| Equitable | 284,670 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 268,350 | 0 | 0 | 0 | For |
Showing the 25 largest of 164 asset managers. See all 164 in the interactive database.
Combines 4 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
CYTEK BIOSCIENCES INC.’s own tally for this item (“Proposal 3: Ratification of the Selection of Independent Registered Public Accounting Firm. The selection of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending”): 94,116,564 for, 2,329,549 against, per its Form 8-K filed 2024-06-11 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 131,272,929 outstanding shares: 72% for, 2% against (73% of the company cast a for/against vote).
The 58 asset managers below cast 99.8% of the shares they voted on this item FOR (33,321,640 for, 59,542 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 11,709,204 | 0 | 0 | 0 | For |
| BlackRock | 8,025,009 | 0 | 0 | 0 | For |
| Brown Capital Management Mutual Funds | 4,548,308 | 0 | 0 | 0 | For |
| Fidelity | 2,040,715 | 0 | 0 | 0 | For |
| State Street | 1,099,201 | 0 | 0 | 0 | For |
| Charles Schwab | 846,176 | 0 | 0 | 0 | For |
| Dimensional | 798,981 | 0 | 0 | 0 | For |
| Hartford | 552,629 | 0 | 0 | 0 | For |
| Northwestern Mutual | 355,511 | 0 | 0 | 0 | For |
| Nationwide | 325,645 | 0 | 0 | 0 | For |
| TIAA | 302,499 | 0 | 0 | 0 | For |
| Equitable | 284,670 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 268,350 | 0 | 0 | 0 | For |
| First Trust | 248,017 | 0 | 0 | 0 | For |
| Jackson National | 227,535 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 211,217 | 0 | 0 | 0 | For |
| Invesco | 163,969 | 0 | 0 | 0 | For |
| American Century | 127,666 | 0 | 0 | 0 | For |
| Principal | 115,655 | 0 | 0 | 0 | For |
| Lincoln Financial | 111,676 | 0 | 0 | 0 | For |
| Prudential/PGIM | 103,207 | 0 | 0 | 0 | For |
| BNY Mellon | 90,513 | 0 | 0 | 0 | For |
| Thrivent | 84,989 | 0 | 0 | 0 | For |
| Empower | 73,155 | 0 | 0 | 0 | For |
| Catholic Responsible Investments Funds | 0 | 59,542 | 0 | 0 | Against |
Showing the 25 largest of 58 asset managers. See all 58 in the interactive database.
Combines 4 wordings of this item as funds reported it.
95% Majority: yes · of votes cast
CYTEK BIOSCIENCES INC.’s own tally for this item (“Elect Director: Michael Holder”): 70,298,785 for, 3,793,589 withheld, per its Form 8-K filed 2024-06-11 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 131,272,929 outstanding shares: 53.6% for, 3% withheld (56% of the company cast a for/withheld vote).
The 56 asset managers below cast 100% of the shares they voted on this item FOR (33,376,751 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 11,709,204 | 0 | 0 | 0 | For |
| BlackRock | 8,025,009 | 0 | 0 | 0 | For |
| Brown Capital Management Mutual Funds | 4,548,308 | 0 | 0 | 0 | For |
| Fidelity | 2,040,715 | 0 | 0 | 0 | For |
| State Street | 1,099,201 | 0 | 0 | 0 | For |
| Charles Schwab | 846,176 | 0 | 0 | 0 | For |
| Dimensional | 798,981 | 0 | 0 | 0 | For |
| Hartford | 552,629 | 0 | 0 | 0 | For |
| Northwestern Mutual | 355,511 | 0 | 0 | 0 | For |
| Nationwide | 325,645 | 0 | 0 | 0 | For |
| TIAA | 302,499 | 0 | 0 | 0 | For |
| Equitable | 284,670 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 268,350 | 0 | 0 | 0 | For |
| First Trust | 248,017 | 0 | 0 | 0 | For |
| Jackson National | 227,535 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 211,217 | 0 | 0 | 0 | For |
| Invesco | 163,969 | 0 | 0 | 0 | For |
| American Century | 127,666 | 0 | 0 | 0 | For |
| Principal | 115,655 | 0 | 0 | 0 | For |
| Lincoln Financial | 111,676 | 0 | 0 | 0 | For |
| Prudential/PGIM | 103,207 | 0 | 0 | 0 | For |
| BNY Mellon | 90,513 | 0 | 0 | 0 | For |
| Thrivent | 84,989 | 0 | 0 | 0 | For |
| Empower | 73,155 | 0 | 0 | 0 | For |
| Catholic Responsible Investments Funds | 59,542 | 0 | 0 | 0 | For |
Showing the 25 largest of 56 asset managers. See all 56 in the interactive database.
Combines 4 wordings of this item as funds reported it.
87% Majority: yes · of votes cast
CYTEK BIOSCIENCES INC.’s own tally for this item (“Elect Director: Wenbin Jiang, Ph.D.”): 64,177,338 for, 9,915,036 withheld, per its Form 8-K filed 2024-06-11 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 131,272,929 outstanding shares: 48.9% for, 8% withheld (56% of the company cast a for/withheld vote).
The 56 asset managers below cast 100% of the shares they voted on this item FOR (31,520,972 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 11,709,204 | 0 | 0 | 0 | For |
| BlackRock | 8,025,009 | 0 | 0 | 0 | For |
| Brown Capital Management Mutual Funds | 4,548,308 | 0 | 0 | 0 | For |
| Fidelity | 2,040,715 | 0 | 0 | 0 | For |
| State Street | 1,086,550 | 0 | 12,651 | 0 | For |
| Charles Schwab | 846,176 | 0 | 0 | 0 | For |
| Dimensional | 0 | 0 | 798,981 | 0 | Abstain |
| Hartford | 552,629 | 0 | 0 | 0 | For |
| Northwestern Mutual | 355,511 | 0 | 0 | 0 | For |
| Nationwide | 302,021 | 0 | 23,624 | 0 | For |
| TIAA | 302,499 | 0 | 0 | 0 | For |
| Equitable | 284,670 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 268,350 | 0 | 0 | 0 | For |
| First Trust | 0 | 0 | 248,017 | 0 | Abstain |
| Jackson National | 217,274 | 0 | 10,261 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 211,217 | 0 | 0 | 0 | For |
| Invesco | 163,969 | 0 | 0 | 0 | For |
| American Century | 0 | 0 | 127,666 | 0 | Abstain |
| Principal | 0 | 0 | 115,655 | 0 | Abstain |
| Lincoln Financial | 102,400 | 0 | 9,276 | 0 | For |
| Prudential/PGIM | 103,207 | 0 | 0 | 0 | For |
| BNY Mellon | 90,513 | 0 | 0 | 0 | For |
| Thrivent | 0 | 0 | 84,989 | 0 | Abstain |
| Empower | 0 | 0 | 73,155 | 0 | Abstain |
| Catholic Responsible Investments Funds | 0 | 0 | 59,542 | 0 | Abstain |
Showing the 25 largest of 56 asset managers. See all 56 in the interactive database.
100% fund support · no official result
The 2 asset managers below cast 100% of the shares they voted on this item FOR (4,431 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| SYNTAX ETF TRUST | 4,231 | 0 | 0 | 0 | For |
| Boltwood Capital Management | 200 | 0 | 0 | 0 | For |
Ranked by the number of CYTEK BIOSCIENCES INC. shares each manager voted on the most widely held ballot item of the 2023-2024 meeting, shown as a share of the 131,272,929 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Vanguard | 9.16% |
| 2 | BlackRock | 7.94% |
| 3 | HHLR ADVISORS, LTD. | 5.07% |
| 4 | BROWN CAPITAL MANAGEMENT LLC | 4.85% |
| 5 | Brown Capital Management Mutual Funds | 3.46% |
| 6 | State Street | 3.25% |
| 7 | RA CAPITAL MANAGEMENT, L.P. | 2.95% |
| 8 | NEW YORK STATE COMMON RETIREMENT FUND | 2.25% |
| 9 | GEODE CAPITAL MANAGEMENT, LLC | 1.62% |
| 10 | Fidelity | 1.56% |
Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).
| Holder | % outstanding | Disclosure |
|---|---|---|
| Entities affiliated with BlackRock, Inc. | 13.54% | DEF14A |
| BlackRock | 12.61% | 13F |
| Entities affiliated with Brown Capital | 9.15% | DEF14A |
| Entities affiliated with The Vanguard Group | 9.06% | DEF14A |
| Vanguard Group | 5.28% | 13F |
| Entities affiliated with RA Capital Management | 5.19% | DEF14A |
| Entities affiliated with HHLR Advisors, Ltd. | 5.07% | DEF14A |
| Ming Yan | 4.73% | 13G |
| Wenbin Jiang | 4.34% | 13G |
| State Street | 3.14% | 13F |
Percentages above are of 131,272,929 shares outstanding, as reported by CYTEK BIOSCIENCES INC. on its Form 10-Q dated 2024-04-30 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from CYTEK BIOSCIENCES INC.’s 10-Q dated 2024-04-30. This page is a static snapshot rebuilt weekly on 04 October 2026; a live search always shows the current data.
At CYTEK BIOSCIENCES INC.'s shareholder meeting held 2024-06-05, in the 2023-2024 proxy season, 164 asset managers reported how they voted in their SEC Form N-PX filings, covering 842 separate fund positions. Their filings are grouped here into 5 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — To vote, on an advisory basis, regarding the compensation of our named executive officers for… — the proposal passed with 86% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: CYTEK BIOSCIENCES INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2024-06-11.
CYTEK BIOSCIENCES INC. proxy season coverage: 2023-2024 (this page) · 2024-2025 · 2025-2026.